
XtalPi, a company that makes use of AI to aid in the discovery and development of drugs, raises $400 million in Series D funding that was led by OrbiMed and RRJ with a market value of $2 billion. – The company offers its AI technology to pharmaceutical companies in order to improve R&D for the development of new drugs. AI pharmaceutical company XtalPi has secured the sum of USD 400 million…
tokyo bangkokbased synqa 120m series c